| Miss Alyssa Kirk Borden, | |
|
757 Westwood Plz Ste 3325, Los Angeles, CA 90095-8358 | |
| (310) 794-4494 | |
| (310) 267-3899 |
| Full Name | Miss Alyssa Kirk Borden |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 3 Years |
| Location | 757 Westwood Plz Ste 3325, Los Angeles, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912583485 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 95001582 (California) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | RN671215 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chestnut Hill Hospital | Philadelphia, PA | Hospital |
| Temple University Hospital | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North American Partners In Anesthesia, Pennsylvania , Llc | 7517960834 | 368 |
News Archive
Because the first national study of its kind has found that U.S. mothers report they are less likely to vaccinate daughters under age 13 against human papillomavirus virus (HPV), even though the vaccine is recommended for girls at age 11 and 12, it's incumbent upon the healthcare community to work to improve moms' acceptance of the vaccination for younger daughters, say researchers at Cincinnati Children's Hospital Medical Center who conducted the study. HPV is a sexually transmitted virus known to cause cervical cancer.
Tobacco control efforts have reduced cigarette smoking for many, but those efforts have disproportionately helped white smokers, while other racial and ethnic groups are still struggling, an Oregon State University researcher's analysis found.
HemoShear LLC, a biotechnology research company and leading developer of human cell-based surrogate systems for discovery and assessment of new drug compounds, today announced that the U.S. Patent and Trademark Office (USPTO) has granted it patent no. 7,811,782 entitled "Use of An In Vitro Hemodynamic Endothelial/Smooth Muscle Cell Co-Culture Model to Identify New Therapeutic Targets for Vascular Disease."
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, has received approval from the U.S. Food and Drug Administration for Dyloject (diclofenac sodium) Injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic.
› Verified 7 days ago
| Entity Name | North American Partners In Anesthesia, Pennsylvania , Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639137854 PECOS PAC ID: 7517960834 Enrollment ID: O20060807000040 |
News Archive
Because the first national study of its kind has found that U.S. mothers report they are less likely to vaccinate daughters under age 13 against human papillomavirus virus (HPV), even though the vaccine is recommended for girls at age 11 and 12, it's incumbent upon the healthcare community to work to improve moms' acceptance of the vaccination for younger daughters, say researchers at Cincinnati Children's Hospital Medical Center who conducted the study. HPV is a sexually transmitted virus known to cause cervical cancer.
Tobacco control efforts have reduced cigarette smoking for many, but those efforts have disproportionately helped white smokers, while other racial and ethnic groups are still struggling, an Oregon State University researcher's analysis found.
HemoShear LLC, a biotechnology research company and leading developer of human cell-based surrogate systems for discovery and assessment of new drug compounds, today announced that the U.S. Patent and Trademark Office (USPTO) has granted it patent no. 7,811,782 entitled "Use of An In Vitro Hemodynamic Endothelial/Smooth Muscle Cell Co-Culture Model to Identify New Therapeutic Targets for Vascular Disease."
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, has received approval from the U.S. Food and Drug Administration for Dyloject (diclofenac sodium) Injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Alyssa Kirk Borden, 5767 W Century Blvd Suite 400, Los Angeles, CA 90095-5631 Ph: (310) 301-8707 | Miss Alyssa Kirk Borden, 757 Westwood Plz Ste 3325, Los Angeles, CA 90095-8358 Ph: (310) 794-4494 |
News Archive
Because the first national study of its kind has found that U.S. mothers report they are less likely to vaccinate daughters under age 13 against human papillomavirus virus (HPV), even though the vaccine is recommended for girls at age 11 and 12, it's incumbent upon the healthcare community to work to improve moms' acceptance of the vaccination for younger daughters, say researchers at Cincinnati Children's Hospital Medical Center who conducted the study. HPV is a sexually transmitted virus known to cause cervical cancer.
Tobacco control efforts have reduced cigarette smoking for many, but those efforts have disproportionately helped white smokers, while other racial and ethnic groups are still struggling, an Oregon State University researcher's analysis found.
HemoShear LLC, a biotechnology research company and leading developer of human cell-based surrogate systems for discovery and assessment of new drug compounds, today announced that the U.S. Patent and Trademark Office (USPTO) has granted it patent no. 7,811,782 entitled "Use of An In Vitro Hemodynamic Endothelial/Smooth Muscle Cell Co-Culture Model to Identify New Therapeutic Targets for Vascular Disease."
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, has received approval from the U.S. Food and Drug Administration for Dyloject (diclofenac sodium) Injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic.
› Verified 7 days ago
Mrs. Cathy Kiem Ngo, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1500 San Pablo St, Los Angeles, CA 90033 Phone: 323-442-7400 | |
Cynthia L Plehn, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4733 W Sunset Blvd, Los Angeles, CA 90027 Phone: 323-783-4011 | |
Mrs. Sara Rondinone Shive, RN, BSN, CRNA, MS Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1500 San Pablo St, Los Angeles, CA 90033 Phone: 323-442-7400 Fax: 323-442-7411 | |
Brandon Lee, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1401 S Grand Ave, Los Angeles, CA 90015 Phone: 213-748-2411 | |
Wesley Adam Easter, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1500 San Pablo St, Los Angeles, CA 90033 Phone: 323-442-7400 | |
Brooke A Knapp, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-2000 | |
Mrs. Dina Marie Hunt, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1500 San Pablo St, Los Angeles, CA 90033 Phone: 323-442-7400 |